Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/31/2023 | Context Therapeutics Inc. | | Grant | Stock Option (right to buy) | 25k | $0.87 | $21.8k | | 05/31/2023 |
02/25/2023 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 135k | $1.78 | $240.3k | | 02/25/2023 |
06/02/2022 | Context Therapeutics Inc. | | Grant | Stock Option (right to buy) | 25k | $2.19 | $54.8k | | 06/02/2022 |
02/28/2022 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 75k | $2.24 | $168k | | 02/28/2022 |
10/08/2021 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 130k | $7.84 | $1M | | 10/08/2021 |
05/28/2015 | ANTARES PHARMA, INC. | ATRS | Grant | Stock option (right to buy) | 142.6k | $2.18 | $310.8k | | 05/28/2015 |
05/28/2015 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 70.2k | $0.00 | $0 | | 05/28/2015 |
05/28/2015 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 2.5k | $2.18 | $5.4k | | 05/28/2015 |
03/10/2015 | ANTARES PHARMA, INC. | ATRS | Grant | Stock option (right to buy) | 47k | $2.62 | $123.1k | | 03/10/2015 |
05/29/2014 | ANTARES PHARMA, INC. | ATRS | Grant | Stock option (right to buy) | 100k | $3.09 | $309k | | 05/29/2014 |
05/29/2014 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 24.3k | $0.00 | $0 | | 05/29/2014 |
05/29/2014 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 48.5k | $0.00 | $0 | | 05/29/2014 |
02/17/2011 | AUXILIUM PHARMACEUTICALS INC | AUXL | Grant | Nonqualified Stock Option (Right to Buy) | 40k | $22.04 | $881.6k | | 02/17/2011 |
03/12/2010 | AUXILIUM PHARMACEUTICALS INC | AUXL | Payment of Exercise | Common Stock | 941 | $30.20 | $28.4k | | 03/12/2010 |